Zepbound and Pregnancy: What to Know When Trying to Conceive

Last reviewed: July 10, 2026

Last updated: July 10, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide and similar GLP-1 receptor agonists have transformed weight management for millions, but pregnancy planning introduces timing questions that deserve clear answers. Current clinical evidence suggests tirzepatide should be discontinued at least 2 months before attempting conception, though individual timelines depend on your health profile and treatment goals. Understanding the safety data helps you make informed decisions alongside your healthcare provider.

Tirzepatide Safety During Pregnancy: What the Evidence Shows

Tirzepatide has not been extensively studied in pregnant people, which is why major health organizations recommend discontinuing GLP-1 medications before conception attempts. Animal reproduction studies showed potential concerns at high doses, though these findings don't automatically predict human outcomes. The FDA classifies tirzepatide in Pregnancy Category C, meaning risks cannot be ruled out but human data remains limited.

No controlled trials have evaluated tirzepatide outcomes in pregnancy because ethical standards prevent exposing pregnant people to untested medications. This absence of safety data—rather than evidence of harm—drives the conservative recommendation to stop treatment before trying to conceive. Your PlexusDx provider can help you plan a discontinuation timeline that maintains metabolic stability while preparing for pregnancy.

When to Stop Tirzepatide Before Trying to Conceive

Medical guidance typically recommends pausing tirzepatide 2 months before actively trying to become pregnant, allowing the medication to fully clear your system. This timeline gives your metabolism time to stabilize and your hormones to return to baseline before conception attempts begin. If you have been on tirzepatide for weight management, stopping suddenly requires a structured approach to prevent rapid weight regain and metabolic disruption.

The discontinuation period serves another purpose: it allows you and your healthcare team to optimize your overall health metrics before pregnancy. Blood sugar regulation, nutritional status, and weight management take on different significance during pregnancy planning. PlexusDx providers can coordinate with your obstetric team to create a transition plan that protects your fertility goals while managing your metabolic health.

Weight Management and Fertility: The Metabolic Connection

Body weight significantly influences fertility outcomes in people trying to conceive, with both obesity and rapid weight loss creating hormonal challenges. Excess body fat increases insulin resistance and alters ovulation patterns, while sudden weight loss can suppress reproductive hormones needed for conception. This means that stopping tirzepatide requires thoughtful planning to maintain the weight loss benefits without destabilizing your fertility.

Many people who successfully lose weight on tirzepatide experience improved ovulation and menstrual regularity as metabolic benefits. Stopping medication doesn't erase these improvements if you establish sustainable eating patterns and physical activity habits during treatment. PlexusDx can help you identify dietary strategies and behavioral changes that maintain your progress after discontinuing tirzepatide, supporting both your fertility timeline and long-term health.

Genetic Testing and Personalized Fertility Planning

The PlexusDx Precision Peptide Genetic Test analyzes GLP1R (rs6923761), FTO (rs9939609), and MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Understanding your peptide pathway genetics reveals whether your weight management success depended on GLP-1 sensitivity or broader metabolic factors. This information helps you and your healthcare provider anticipate metabolic changes during the discontinuation period and design strategies to maintain stability while trying to conceive. The test costs $99 as an add-on after your first month of treatment, providing personalized data that informs your entire fertility journey.

Coordinating Care: Your PlexusDx Provider and OB/GYN Team

Managing pregnancy planning on tirzepatide requires communication between your weight management provider and your obstetric care team. PlexusDx providers understand GLP-1 discontinuation protocols and can coordinate timing with your fertility specialist or OB/GYN to create a unified treatment plan. This collaboration ensures your pregnancy preparation receives support across all health dimensions—metabolic, reproductive, and nutritional.

Before stopping tirzepatide, inform your PlexusDx team that you're planning pregnancy so you can receive guidance on the transition period and alternative approaches to maintaining your metabolic health. Your OB/GYN should know about your recent GLP-1 treatment when you begin conception attempts, helping them establish baseline metabolic expectations for your pregnancy. PlexusDx can provide documentation of your treatment timeline and metabolic improvements to support comprehensive prenatal planning.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $289/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can I take tirzepatide while trying to become pregnant?

No, medical guidance recommends discontinuing tirzepatide at least 2 months before attempting conception because the medication has not been studied in pregnancy. While evidence of direct harm is limited, the lack of safety data in pregnant people makes discontinuation the standard recommendation. Your PlexusDx provider can create a personalized discontinuation plan that supports your fertility timeline.

Will I regain weight after stopping tirzepatide before pregnancy?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GLP1R, GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

How much does PlexusDx tirzepatide cost, and is it available before conception planning?

PlexusDx compounded tirzepatide injection starts at $289/mo (or $249/mo on the 6-month plan) across all commitment tiers, with no flat per-compound pricing changes—your dose may need to go up, but your price won't. It's available to all 50 states without insurance or membership fees and qualifies for HSA/FSA accounts. The Precision Peptide Genetic Test costs $99 as an add-on after your first month of treatment.

What happens to my metabolic health after stopping tirzepatide?

Your metabolism stabilizes over 2-3 months after discontinuing tirzepatide, with insulin sensitivity and glucose regulation returning to baseline levels. Weight management success depends on sustaining the dietary and activity habits you built during treatment rather than the medication itself. PlexusDx providers can guide this transition to support both your fertility planning and long-term metabolic stability.

How does genetic testing help with pregnancy planning after GLP-1 therapy?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GLP1R, GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Fridays Zepbound
• Hims Zepbound
• Form Health Zepbound
• Brello Zepbound

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.